Related Experiment Video
Updated: Jun 19, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Inflammatory systemic biomarkers in setting acute coronary syndromes--effects of the diurnal variation
A Dominguez-Rodriguez1, P Abreu-Gonzalez, J C Kaski
1Department of Cardiology (Coronary Care Unit), University Hospital of Canarias, Tenerife, Spain. adrvdg@hotmail.com
Insights
Diurnal variations significantly impact inflammatory biomarkers in acute coronary syndrome. Understanding these daily changes is crucial for accurate blood sample analysis and effective patient risk assessment in cardiovascular disease.
Area of Science:
- Cardiovascular Medicine
- Immunology
- Biomarker Discovery
Background:
- Cardiovascular diseases (CVD) involve persistent immune activation and inflammation, detectable in both vascular walls and peripheral blood.
- Patients with coronary artery disease exhibit elevated inflammatory markers, including neutrophils, T cells, and specific mediators.
- Cardiovascular events often show a diurnal pattern, with a peak incidence in the early morning hours.
Purpose of the Study:
- To review the impact of diurnal variations on key inflammatory systemic biomarkers in acute coronary syndrome (ACS).
- To highlight the importance of understanding diurnal variations for accurate analysis of blood-derived samples in ACS patients.
Main Methods:
- Review of existing studies on diurnal variations in inflammatory markers in ACS.
- Focus on specific biomarkers: interleukin-6, neopterin, matrix metalloproteinases, vascular cell adhesion molecule-1, intercellular adhesion molecule-1, soluble CD40 ligand, and C-reactive protein.
Main Results:
- Diurnal variations are documented in several inflammatory systemic markers in patients with ACS.
- These temporal changes can significantly alter the analysis of blood samples.
- Knowledge of diurnal variations is essential for controlling their impact on diagnostic accuracy.
Conclusions:
- Diurnal variations represent a critical factor influencing the measurement and interpretation of inflammatory biomarkers in ACS.
- Accounting for diurnal fluctuations is necessary for precise risk stratification and effective management of patients with acute coronary syndrome.
- Further research should consider the temporal dynamics of biomarkers for improved clinical utility in cardiovascular disease assessment.
Abstract:
Clinicians have used additional tools to aid clinical assessment and to enhance their ability to identify the "vulnerable" patient at risk for cardiovascular diseases. Circulating biomarkers are one such tool used for identifying better high-risk individuals and to prognosticate effectively and treat patients with disease. A persistent immune activation is a main feature of atherosclerosis. The inflammatory activity is not only detectable in the vascular wall, but also in peripheral blood. Patients with coronary artery disease show increased numbers of neutrophils and T cells as well as elevated levels of several inflammatory mediators. On the other hand, several cardiovascular disease states show a daily cycle of activity, i.e. a peak incidence of cerebrovascular and cardiovascular events has been documented in the early morning hours. Several studies have shown diurnal variations in inflammatory systemic markers in patients with acute coronary syndrome. Diurnal variations can alter the analysis of blood-derived samples. Prior to the analysis of a blood sample, multiple steps are necessary to generate the desired specimen. The knowledge of diurnal variations is a prerequisite to understand and control their impact. This brief review comments the effect of the diurnal variation on the most important inflammatory systemic biomarkers in the setting acute coronary syndrome: interleukin-6, neopterin, matrix metalloproteinases, vascular cell adhesion molecule-1, intercellular adhesión molecule-1, soluble CD40 ligand, and C-reactive protein.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Acute Inflammation III: Local and Systemic Effects